Markovic SN - Search Results

1

The immunologic balance: three cases of rituximab-associated melanoma.

Davidson TM, Markovic SN, Dimou A. Davidson TM, et al. Among authors: markovic sn. Melanoma Res. 2022 Feb 1;32(1):67-70. doi: 10.1097/CMR.0000000000000799. Melanoma Res. 2022. PMID: 34783721

2

Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine.

Block MS, Suman VJ, Nevala WK, Kottschade LA, Creagan ET, Kaur JS, Quevedo JF, McWilliams RR, Markovic SN. Block MS, et al. Among authors: markovic sn. Melanoma Res. 2011 Oct;21(5):438-45. doi: 10.1097/CMR.0b013e32834640c0. Melanoma Res. 2011. PMID: 21697748 Clinical Trial.

3

Regional lymphatic immunity in melanoma.

Grotz TE, Mansfield AS, Jakub JW, Markovic SN. Grotz TE, et al. Among authors: markovic sn. Melanoma Res. 2012 Feb;22(1):9-18. doi: 10.1097/CMR.0b013e32834e1f33. Melanoma Res. 2012. PMID: 22082957 Review.

4

c-MET expression in primary and liver metastases in uveal melanoma.

Gardner FP, Serie DJ, Salomao DR, Wu KJ, Markovic SN, Pulido JS, Joseph RW. Gardner FP, et al. Among authors: markovic sn. Melanoma Res. 2014 Dec;24(6):617-20. doi: 10.1097/CMR.0000000000000118. Melanoma Res. 2014. PMID: 25211165

5

The Mayo Clinic experience with the use of kinase inhibitors, ipilimumab, bevacizumab, and local therapies in the treatment of metastatic uveal melanoma.

Moser JC, Pulido JS, Dronca RS, McWilliams RR, Markovic SN, Mansfield AS. Moser JC, et al. Among authors: markovic sn. Melanoma Res. 2015 Feb;25(1):59-63. doi: 10.1097/CMR.0000000000000125. Melanoma Res. 2015. PMID: 25396683

6

Ipilimumab-induced colitis in patients with metastatic melanoma.

De Felice KM, Gupta A, Rakshit S, Khanna S, Kottschade LA, Finnes HD, Papadakis KA, Loftus EV Jr, Raffals LE, Markovic SN. De Felice KM, et al. Among authors: markovic sn. Melanoma Res. 2015 Aug;25(4):321-7. doi: 10.1097/CMR.0000000000000165. Melanoma Res. 2015. PMID: 25933207

7

The use of pembrolizumab for the treatment of metastatic uveal melanoma.

Kottschade LA, McWilliams RR, Markovic SN, Block MS, Villasboas Bisneto J, Pham AQ, Esplin BL, Dronca RS. Kottschade LA, et al. Among authors: markovic sn. Melanoma Res. 2016 Jun;26(3):300-3. doi: 10.1097/CMR.0000000000000242. Melanoma Res. 2016. PMID: 26848796

8

Antibody-Targeted Chemotherapy for the Treatment of Melanoma.

Nevala WK, Buhrow SA, Knauer DJ, Reid JM, Atanasova EA, Markovic SN. Nevala WK, et al. Among authors: markovic sn. Cancer Res. 2016 Jul 1;76(13):3954-64. doi: 10.1158/0008-5472.CAN-15-3131. Epub 2016 Apr 28. Cancer Res. 2016. PMID: 27197186

9

Galectin-9 modulates immunity by promoting Th2/M2 differentiation and impacts survival in patients with metastatic melanoma.

Enninga EA, Nevala WK, Holtan SG, Leontovich AA, Markovic SN. Enninga EA, et al. Among authors: markovic sn. Melanoma Res. 2016 Oct;26(5):429-41. doi: 10.1097/CMR.0000000000000281. Melanoma Res. 2016. PMID: 27455380 Free PMC article.

10

Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma.

Failing JJ, Finnes HD, Kottschade LA, Allred JB, Markovic SN. Failing JJ, et al. Among authors: markovic sn. Melanoma Res. 2016 Dec;26(6):609-615. doi: 10.1097/CMR.0000000000000299. Melanoma Res. 2016. PMID: 27603551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters